Evidence map›Paper›PMID 33731760›Full record

ArticleScientific reports2021

Composition of receptor tyrosine kinase-mediated lipid micro-domains controlled by adaptor protein interaction.

Arndt Rohwedder, Sabine Knipp, Lee D Roberts, John E Ladbury

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Single-Molecule FRET-Tracking of InlB-Activated MET Receptors in Living Cells.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLCγ1 signaling through Src-family kinases.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arndt RohwedderSchool of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
Sabine KnippSchool of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
Lee D RobertsLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, LS29JT, UK.
John E LadburySchool of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK. j.e.ladbury@leeds.ac.uk.
University of Leeds · GB

Funding

Cancer Research UK 22356Cancer Research UK C57233/A22356
6 · The paper itself

Abstract

Receptor tyrosine kinases (RTKs) are highly regulated, single pass transmembrane proteins, fundamental to cellular function and survival. Aberrancies in regulation lead to corruption of signal transduction and a range of pathological outcomes. Although control mechanisms associated with the receptors and their ligands are well understood, little is known with respect to the impact of lipid/lipid and lipid/protein interactions in the proximal plasma membrane environment. Given that the transmembrane regions of RTKs change in response to extracellular ligand binding, the lipid interactions have important consequences in influencing signal transduction. Fibroblast growth factor receptor 2 (FGFR2) is a highly regulated RTK, including under basal conditions. Binding of the adaptor protein, growth factor receptor-bound protein 2 (GRB2) to FGFR2 prevents full activation and recruitment of downstream signalling effector proteins in the absence of extracellular stimulation. Here we demonstrate that the FGFR2-GRB2 complex is sustained in a defined lipid environment. Dissociation of GRB2 from this complex due to ligand binding, or reduced GRB2 expression, facilitates the dispersion of FGFR2 into detergent-resistant membrane (DRM) micro-domains. This modification of the plasma membrane proximal to FGFR2 provides a further regulatory checkpoint which controls receptor degradation, recycling and recruitment of intracellular signalling proteins.

Indexed as

Cell MembraneGRB2 Adaptor ProteinHEK293 CellsHumansLigandsProtein BindingProtein DomainsReceptor, Fibroblast Growth Factor, Type 2FGFR2 protein, humanGRB2 Adaptor ProteinGRB2 protein, humanLigandsReceptor, Fibroblast Growth Factor, Type 2

Identifiers

PMID33731760
PMCPMC7969938
OpenAlexW3136339941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.